These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 8575511)
1. Effects of a selective alpha 2-adrenoceptor antagonist, atipamezole, on hypothalamic histamine and noradrenaline release in vivo. Laitinen KS; Tuomisto L; MacDonald E Eur J Pharmacol; 1995 Oct; 285(3):255-60. PubMed ID: 8575511 [TBL] [Abstract][Full Text] [Related]
2. Overflow of noradrenaline and dopamine in frontal cortex after [N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine] (DSP-4) treatment: in vivo microdialysis study in anaesthetized rats. Kask A; Harro J; Tuomaine P; Rägo L; Männistö PT Naunyn Schmiedebergs Arch Pharmacol; 1997 Feb; 355(2):267-72. PubMed ID: 9050022 [TBL] [Abstract][Full Text] [Related]
3. Differences in the mechanisms that increase noradrenaline efflux after administration of d-amphetamine: a dual-probe microdialysis study in rat frontal cortex and hypothalamus. Géranton SM; Heal DJ; Stanford SC Br J Pharmacol; 2003 Aug; 139(8):1441-8. PubMed ID: 12922931 [TBL] [Abstract][Full Text] [Related]
4. The alpha 2-adrenoceptor antagonist atipamezole potentiates anti-Parkinsonian effects and can reduce the adverse cardiovascular effects of dopaminergic drugs in rats. Haapalinna A; Leino T; Heinonen E Naunyn Schmiedebergs Arch Pharmacol; 2003 Nov; 368(5):342-51. PubMed ID: 14566451 [TBL] [Abstract][Full Text] [Related]
5. In vivo modulation of the histamine release in the hypothalamus by adrenoreceptor agonists and antagonists. Prast H; Heistracher M; Philippu A Naunyn Schmiedebergs Arch Pharmacol; 1991 Aug; 344(2):183-6. PubMed ID: 1719433 [TBL] [Abstract][Full Text] [Related]
6. Noradrenergic terminals are the primary source of α Devoto P; Flore G; Saba P; Scheggi S; Mulas G; Gambarana C; Spiga S; Gessa GL Prog Neuropsychopharmacol Biol Psychiatry; 2019 Mar; 90():97-103. PubMed ID: 30472147 [TBL] [Abstract][Full Text] [Related]
7. The effect of a selective alpha2-adrenoceptor antagonist on pain behavior of the rat varies, depending on experimental parameters. Kauppila T; Jyväsjärvi E; Hämäläinen MM; Pertovaara A Pharmacol Biochem Behav; 1998 Feb; 59(2):477-85. PubMed ID: 9476998 [TBL] [Abstract][Full Text] [Related]
8. In vivo modulation of rat hypothalamic histamine release by the histamine H3 receptor ligands, immepip and clobenpropit. Effects of intrahypothalamic and peripheral application. Jansen FP; Mochizuki T; Yamamoto Y; Timmerman H; Yamatodani A Eur J Pharmacol; 1998 Dec; 362(2-3):149-55. PubMed ID: 9874165 [TBL] [Abstract][Full Text] [Related]
9. Characterization of noradrenaline release in the locus coeruleus of freely moving awake rats by in vivo microdialysis. Fernández-Pastor B; Mateo Y; Gómez-Urquijo S; Javier Meana J Psychopharmacology (Berl); 2005 Jul; 180(3):570-9. PubMed ID: 15717207 [TBL] [Abstract][Full Text] [Related]
10. Endogenous serotonin modulates histamine release in the rat hypothalamus as measured by in vivo microdialysis. Laitinen KS; Tuomisto L; Laitinen JT Eur J Pharmacol; 1995 Oct; 285(2):159-64. PubMed ID: 8566134 [TBL] [Abstract][Full Text] [Related]
11. Behavioural and neurochemical effects of antipamezole, a novel alpha 2-adrenoceptor antagonist. Scheinin H; MacDonald E; Scheinin M Eur J Pharmacol; 1988 Jun; 151(1):35-42. PubMed ID: 2901363 [TBL] [Abstract][Full Text] [Related]
12. Behavioral effects of the alpha(2)-adrenoceptor antagonist, atipamezole, after focal cerebral ischemia in rats. Jolkkonen J; Puurunen K; Rantakömi S; Härkönen A; Haapalinna A; Sivenius J Eur J Pharmacol; 2000 Jul; 400(2-3):211-9. PubMed ID: 10988336 [TBL] [Abstract][Full Text] [Related]
13. Studies on the control of gonadotrophin release in the gonadectomized male rat: evidence for a lack of involvement of the hypothalamic noradrenergic system in the long-term castrated rat. Herdon HJ; Everard DM; Wilson CA J Endocrinol; 1984 Feb; 100(2):235-44. PubMed ID: 6141209 [TBL] [Abstract][Full Text] [Related]
14. Contrasting effects of the imidazol(in)e alpha 2-adrenoceptor agonists, medetomidine, clonidine and UK 14,304 on extraneuronal levels of noradrenaline in the rat frontal cortex: evaluation using in vivo microdialysis and synaptosomal uptake studies. Dalley JW; Stanford SC Br J Pharmacol; 1995 Apr; 114(8):1717-23. PubMed ID: 7599940 [TBL] [Abstract][Full Text] [Related]
15. Effect of alpha 2-adrenergic drugs dexmedetomidine and atipamezole on extracellular amino acid levels in vivo. Valtonen P; Haapalinna A; Riekkinen P; Halonen T Eur J Pharmacol; 1995 Oct; 285(3):239-46. PubMed ID: 8575509 [TBL] [Abstract][Full Text] [Related]
16. In vivo tonic modulation of the noradrenaline release in the rat cortex by locus coeruleus somatodendritic alpha(2)-adrenoceptors. Fernández-Pastor B; Meana JJ Eur J Pharmacol; 2002 May; 442(3):225-9. PubMed ID: 12065075 [TBL] [Abstract][Full Text] [Related]
17. Histamine regulates food intake through modulating noradrenaline release in the para-ventricular nucleus. Kurose Y; Terashima Y Brain Res; 1999 May; 828(1-2):115-8. PubMed ID: 10320730 [TBL] [Abstract][Full Text] [Related]
18. Comparison of the effects of acute and subchronic administration of atipamezole on reaction to novelty and active avoidance learning in rats. Haapalinna A; MacDonald E; Viitamaa T; Salonen JS; Sirviö J; Virtanen R Naunyn Schmiedebergs Arch Pharmacol; 1999 Mar; 359(3):194-203. PubMed ID: 10208306 [TBL] [Abstract][Full Text] [Related]
19. Different acute effects of the tyrosine hydroxylase inhibitors alpha-methyl-p-tyrosine and 3-iodo-L-tyrosine on hypothalamic noradrenaline activity and adrenocorticotrophin release in the rat. Smythe GA; Bradshaw JE Aust J Biol Sci; 1983; 36(5-6):519-23. PubMed ID: 6144300 [TBL] [Abstract][Full Text] [Related]